Terracotta tiles can be a stunning addition in any home. And luckily, there are several styles to choose from to ensure they ...

There are several design trends that are making a comeback in 2025, including a timeless window treatment. Here's how to ...

Chris Evans and Jason Statham 's forgotten thriller Cellular has been released on Netflix. The 2004 movie follows a science ...

Need custom window coverings for a new home, a stylish upgrade or lower energy bills? Sunburst Shutters & Window Fashions, with over 50 years of expertise, delivers solutions that ...

The global window coverings market is estimated to be valued at USD 23 billion in 2023 and is projected to reach USD 35 ...

A clever new set of glasses may offer new hope to people with macular degeneration. By copying the structure of a fly's eyes, ...

Looking to block out the sun and add a stylish touch to your home? In this Home Zone project, we’re tackling window coverings ...

Johnson & Johnson and Intra-Cellular Therapies, Inc. have announced that they have entered into a definitive agreement under ...

Johnson & Johnson has agreed to acquire Intra-Cellular Therapies for approximately $14.6 billion, in the largest biopharma merger-and-acquisition (M&A) deal announced in two years.

As the cold winter weather sets in, keeping your home warm and energy-efficient becomes a top priority. One of the biggest ...

New Brunswick-based Johnson & Johnson and Bedminster-based Intra-Cellular Therapies, Inc. have entered into a definitive agreement ...

Intra-Cellular recently guided to at least $5 billion in peak Caplyta sales. Intra-Cellular’s stock was trading at $127.48, up $32.61, or 34%. J&J’s stock (NYSE:JNJ) was selling for $143.39, up $1.34.